Glen Harbor Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Glen Harbor Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$442K	Buy	4,592 +560	+14%	+$62.5K	0.01%	743
2019 Q2	$464K	Buy	4,032 +252	+7%	+$30.2K	0.01%	727
2019 Q1	$445K	Sell	3,780 -1,484	-28%	-$130K	0.01%	718
2018 Q4	$330K	Sell	5,264 -3,864	-42%	-$243K	0.01%	765
2018 Q3	$647K	Buy	9,128 +280	+3%	+$19.3K	0.01%	611
2018 Q2	$589K	Buy	8,848 +952	+12%	+$62.6K	0.01%	591
2018 Q1	$516K	Buy	+7,896	New	+$444K	0.01%	624

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Glen Harbor Capital Management's ASND Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Ascendis Pharma A/S (ASND) stake by 14% in Q3 2019, buying an estimated $62.5K and bringing the position to 4,592 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #743.

Glen Harbor Capital Management first reported a position in ASND in Q1 2018 and has held it in 7 quarters since. The position peaked at $647K in Q3 2018. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

Glen Harbor Capital Management held 4,592 shares of Ascendis Pharma A/S worth $442K as of Q3 2019.
Glen Harbor Capital Management bought 560 Ascendis Pharma A/S shares in Q3 2019, an estimated $62.5K.
Ascendis Pharma A/S made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #743 holding.
Glen Harbor Capital Management first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 7 quarters since.
Glen Harbor Capital Management's Ascendis Pharma A/S position peaked at $647K in Q3 2018.
129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.